"The justly celebrated unraveling of the LDL receptor pathway revealed that mutations in a single gene give rise to familial hypercholesterolemia (FH)," Peter Libby, MD, PhD, of Brigham and Women ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window High "bad" cholesterol, or hypercholesterolemia, affects about 10% of adults in the United States and about 7% of youth ...
Expert opinion from Shobha S Reddy MBBS, Masters in Diabetology, General Practitioner & Diabetologist · 15 years of ...
Expert opinion from Shobha S Reddy MBBS, Masters in Diabetology, General Practitioner & Diabetologist · 15 years of ...
Here’s everything you need to know about how to lower cholesterol and why this marker of cardiovascular health is so ...
Clin Lipidology. 2013;8(4):407-409. Homozygous familial hypercholesterolemia is a rare but significant cause of early-onset coronary heart disease. Early detection and diagnosis is crucial in at ...
Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL ...
One of the most common signs of PAD appears when walking. Some people develop a “painful” ache in their legs when they walk, ...
OBJECTIVES/GOALS: Familial Hypercholesterolemia (FH) is a common disorder that is vastly underdiagnosed and causes an increased risk for sudden cardiac death. Cardiology providers (CHCPs) are in an ...
Regeneron Pharmaceuticals has collaborated with Mammoth Biosciences to develop in vivo clustered regularly interspaced short ...
Across robust slate of presentations, company highlights compelling new data and strong differentiation -SOUTH SAN FRANCISCO, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results